Cancer stem cell heterogeneity‑inspired therapeutics for enhancing tumor treatment outcomes (Review)
International Journal of Oncology · 2025
DOI: 10.3892/ijo.2025.5831 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Oncology, 2025. Verfasst von Hanning Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center of Gastroenterology Department, Tianyou Hospital, Affiliated to College of Medicine, Wuhan University of Science and Technol…. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Cancer stem cells (CSCs), a small subpopulation of cancer cells that exhibit stem‑like properties, possess the ability to differentiate and self‑renew. These capabilities enable CSCs to act as tumor‑initiating cells, driving tumorigenesis and proliferation, leading to major clinical challenges. Specifically, CSCs play a crucial role in metastasis, recurrence and drug resistance, thereby leading to complications in therapeutic responses. The plasticity of CSCs leads to heterogeneity, allowing them to adopt diverse phenotypes in response to intrinsic genetic factors or extrinsic environmental cues. This adaptability may serve as a mechanism for CSCs to thrive in the tumor microenvironment (TME) and promote tumor progression. The present article aimed to review the multifaceted nature of CSCs, examining their functional diversity, biomarkers and interactions with the TME. Through elucidating the mechanisms that underlie this heterogeneity, researchers aim to develop targeted therapeutic interventions against CSCs, thereby enhancing the efficacy of cancer treatments and improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Center of Gastroenterology Department, Tianyou Hospital, Affiliated to College of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei 430065, P.R. China.
- Hanchuan Center for Disease Control and Prevention, Hanchuan, Hubei 431699, P.R. China.
Zitieren
APA
Xu, H., Si, Q., Song, Y., Sun, S., Wei, X., Long, H., & Wang, X. (2025). Cancer stem cell heterogeneity‑inspired therapeutics for enhancing tumor treatment outcomes (Review). International Journal of Oncology. https://doi.org/10.3892/ijo.2025.5831
Vancouver
Xu H, Si Q, Song Y, Sun S, Wei X, Long H, et al. Cancer stem cell heterogeneity‑inspired therapeutics for enhancing tumor treatment outcomes (Review). International Journal of Oncology. 2025. doi:10.3892/ijo.2025.5831
BibTeX
@article{Xu2025,
author = {Xu, Hanning and Si, Qunchao and Song, Yongyao and Sun, Shengping and Wei, Xianghong and Long, Hui and Wang, Xiaomei},
title = {Cancer stem cell heterogeneity‑inspired therapeutics for enhancing tumor treatment outcomes (Review)},
journal = {International Journal of Oncology},
year = {2025},
doi = {10.3892/ijo.2025.5831}
}
EUVIMED